Search Results - mathew+memoli

1 Results

Sort By:

Intranasal or Inhaled Delivery of a Custom IgA Antibody for Protection Against COVID-19

This technology includes an IgA antibody, specifically designed to target the receptor binding domain of SARS-CoV-2, the virus causing COVID-19. Administered intranasally, this antibody has potential neutralizing activity, aiming to prevent COVID-19. IgA, an antibody class present in mucosal areas, plays a crucial role in immune defense at the initial...

Published: 8/12/2024 | Inventor(s): Kaitlyn Sadtler, Mathew Memoli

Keywords(s):

Category(s): Application > Therapeutics, Collaboration Sought > Licensing, ResearchProducts > Antibodies, TherapeuticArea > Infectious Disease